Sign In
Buy ZEAL
$17.59
+0 (+0%)
At Close: Jan 27, 2023
Zealand touts promising tolerability data for obesity drug in mid-stage study
04:47pm, Friday, 05'th Jun 2026
Zealand Pharma said on Friday its experimental obesity drug, co-developed with Swiss partner Roche , showed encouraging tolerability in a mid-stage trial, bolstering its push to take on market lead
Press release – No. 13 / 2026 New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight m
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
11:00am, Tuesday, 02'nd Jun 2026
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.
Zealand Pharma - Transactions related to share buy-back program (week 22, 2026)
11:00am, Monday, 01'st Jun 2026
Company announcement No. 20 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand
Company announcement – No. 19 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenh
Zealand Pharma to participate in the Jefferies Global Healthcare Conference
11:00am, Wednesday, 27'th May 2026
Press release – No. 11 / 2026 Zealand Pharma to participate in the Jefferies Global Healthcare Conference Copenhagen, Denmark, May 27, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no.
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
03:00am, Wednesday, 27'th May 2026
Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as eP
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
11:30am, Tuesday, 26'th May 2026
Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ("the Company" or “Zealand
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
10:00am, Tuesday, 26'th May 2026
Company announcement – No. 17 / 2026 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 Copenhagen, Denmark, May 26, 2026 - Zealand Pharma A/S ("Zealand Pharma" or the “Company�
Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
11:00am, Thursday, 14'th May 2026
Company announcement No. 16 / 2026 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ("the Company" or “Zea
Zealand Pharma - Execution framework for share buy-back program
01:05am, Thursday, 07'th May 2026
Company announcement No. 15 / 2026 Zealand Pharma - Execution framework for share buy-back program Copenhagen, Denmark, May 7, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasd
Zealand Pharma Announces Financial Results for the First Three Months of 2026
01:00am, Thursday, 07'th May 2026
Company announcement – No. 14 / 2026 Zealand Pharma Announces Financial Results for the First Three Months of 2026 A defining start to 2026, marked by pivotal progress for leading obesity assets, pe
Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
12:55am, Thursday, 07'th May 2026
Company announcement No. 13 / 2026 Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program Robust cash position of USD 2.3 billion (DKK 14.5 billion) as of March 31, 2026 Fin
Press release - No. 9 / 2026 The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting Camilla Sylvest will bring d
Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026
09:00am, Friday, 01'st May 2026
Company announcement – No. 12 / 2026 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma
